Leukemia & Lymphoma, Volume 52, Issue 6 (2011)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Leukemia & Lymphoma, Volume 52, Issue 6 (2011)

See all volumes and issues
Vol 65, 2024 Vol 64, 2023 Vol 63, 2022 Vol 62, 2021 Vol 61, 2020 Vol 60, 2019 Vol 59, 2018 Vol 58, 2017 Vol 57, 2016 Vol 56, 2015 Vol 55, 2014 Vol 54, 2013 Vol 53, 2012 Volume 52, 2011 Vol 51, 2010 Vol 50, 2009 Vol 49, 2008 Vol 48, 2007 Vol 47, 2006 Vol 46, 2005 Vol 45, 2004 Vol 44, 2003 Vol 43, 2002 Vol 42, 2001 Vol 41, 2001 Vol 40, 2000-2001 Vol 39, 2000 Vol 38, 2000 Vol 37, 2000 Vol 36, 1999-2000 Vol 35, 1999 Vol 34, 1999 Vol 33, 1999 Vol 32, 1998-1999 Vol 31, 1998 Vol 30, 1998 Vol 29, 1998 Vol 28, 1997-1998 Vol 27, 1997 Vol 26, 1997 Vol 25, 1997 Vol 24, 1996-1997 Vol 23, 1996 Vol 22, 1996 Vol 21, 1996 Vol 20, 1995-1996 Vol 19, 1995 Vol 18, 1995 Vol 17, 1995 Vol 16, 1995 Vol 15, 1995 Vol 16, 1995 Vol 15, 1995 Vol 14, 1994 Vol 13, 1994 Vol 12, 1993-1994 Vol 11, 1993 Vol 10, 1993 Vol 9, 1993 Vol 8, 1992 Vol 7, 1992 Vol 6, 1991-1992 Vol 5, 1991 Vol 4, 1991 Vol 3, 1990-1991 Vol 2, 1990 Vol 1, 1989-1990
Download citations Download PDFs

Commentary on selected articles in this issue

Article Commentary
Strategies to optimize collection of hematopoietic stem cells in patients with mantle cell lymphoma receiving hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate-chemotherapy
Kirsten E. Herbert, David S. Ritchie & John F. Seymour
Pages: 935-937
Published online: 23 May 2011
First Page PreviewforStrategies to optimize collection of hematopoietic stem cells in patients with mantle cell lymphoma receiving hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate-chemotherapy | Full Text | References | PDF (244 KB) | Supplemental
  • 778 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Old versus frail: why it matters in lymphoma
Erika Ramsdale & Sonali Smith
Pages: 938-940
Published online: 23 May 2011
First Page PreviewforOld versus frail: why it matters in lymphoma | Full Text | References | PDF (239.5 KB) | Supplemental
  • 640 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Genotyping chronic lymphocytic leukemia in China: East meets West
Deborah Rund
Pages: 941-942
Published online: 23 May 2011
CitationforGenotyping chronic lymphocytic leukemia in China: East meets West | Full Text | References | PDF (133.3 KB) | Supplemental
  • 451 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
The significance of quantifiable residual normal karyotype hematopoietic cells for toxicity and outcome
Carlos Vigil, Annemarie W. Block & Meir Wetzler
Page: 943
Published online: 23 May 2011
CitationforThe significance of quantifiable residual normal karyotype hematopoietic cells for toxicity and outcome | Full Text | References | PDF (233.9 KB) | Supplemental
  • 357 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Vive la résistance: stem cells in mantle cell lymphoma
R. Eric Davis & Jason R. Westin
Pages: 944-945
Published online: 04 Apr 2011
CitationforVive la résistance: stem cells in mantle cell lymphoma | Full Text | References | PDF (236.9 KB) | Supplemental
  • 545 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes
Clive S. Zent, Aaron Polliack & Tamar Tadmor
Pages: 946-947
Published online: 03 May 2011
CitationforFISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes | Full Text | References | PDF (241.2 KB) | Supplemental
  • 520 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article Commentary
Anaerobes: not to be forgotten in neutropenic fever
Iain J. Abbott & Monica A. Slavin
Pages: 948-949
Published online: 03 May 2011
CitationforAnaerobes: not to be forgotten in neutropenic fever | Full Text | References | PDF (236.9 KB) | Supplemental
  • 838 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Reviews

Review Article
Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update
Daan Dierickx, Thomas Tousseyn, Christiane De Wolf-Peeters, Jacques Pirenne & Gregor Verhoef
Pages: 950-961
Published online: 21 Feb 2011
AbstractforManagement of posttransplant lymphoproliferative disorders following solid organ transplant: an update | Full Text | References | PDF (572.1 KB) | Supplemental
  • 379 Views
  • 17 CrossRef citations
  • 0Altmetric
Review Article
Current concepts and controversies in the management of early stage Hodgkin lymphoma
Lauren S. Maeda, Mark Lee & Ranjana H Advani
Pages: 962-971
Published online: 04 Apr 2011
AbstractforCurrent concepts and controversies in the management of early stage Hodgkin lymphoma | Full Text | References | PDF (192.3 KB) | Supplemental
  • 331 Views
  • 5 CrossRef citations
  • 0Altmetric
Review Article
Quality of life domains among non-Hodgkin lymphoma survivors: an integrative literature review
Ashley Leak, Deborah K. Mayer & Sophia Smith
Pages: 972-985
Published online: 03 May 2011
AbstractforQuality of life domains among non-Hodgkin lymphoma survivors: an integrative literature review | Full Text | References | PDF (284.3 KB) | Supplemental
  • 529 Views
  • 20 CrossRef citations
  • 0Altmetric

Original Articles: Clinical

Article
Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma
Brian T. Hill, Lisa Rybicki, Stephen Smith, Robert Dean, Matt Kalaycio, Brad Pohlman, John Sweetenham, Shawnda Tench, Ronald Sobecks, Steven Andresen, Edward Copelan & Brian J. Bolwell
Pages: 986-993
Published online: 14 Feb 2011
AbstractforTreatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma | Full Text | References | PDF (173 KB) | Supplemental
  • 257 Views
  • 21 CrossRef citations
  • 0Altmetric
Article
Diffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines
Brian K. Link, John Brooks, Kara Wright, Xiaoyun Pan, Margaret Voelker & Elizabeth Chrischilles
Pages: 994-1002
Published online: 21 Feb 2011
AbstractforDiffuse large B-cell lymphoma in the elderly: diffusion of treatment with rituximab and survival advances with and without anthracyclines | Full Text | References | PDF (757.4 KB) | Supplemental
  • 515 Views
  • 32 CrossRef citations
  • 0Altmetric
Article
Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population
Hua-Jie Dong, Kou-Rong Miao, Chun Qiao, Yun Zhuang, Wen-Yi Shen, Ming Hong, Lei Fan, Peng Liu, Wei XU & Jian-Yong Li
Pages: 1003-1009
Published online: 04 Apr 2011
AbstractforPolymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population | Full Text | References | PDF (167.1 KB) | Supplemental
  • 150 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Does pretreatment fluorescence in situ hybridization for BCR–ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?
Lisa M. Lima, Keeran Sampat, Sarit Assouline, Debra Saxe, Sharron Nault, Mourad Tighiouart, Morgan Mclemore, Martha Arellano, Elliott Winton, Leon Bernal-Mizrachi, Jorge Cortes & Hanna Jean Khoury
Pages: 1010-1016
Published online: 20 Apr 2011
AbstractforDoes pretreatment fluorescence in situ hybridization for BCR–ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia? | Full Text | References | PDF (387.8 KB) | Supplemental
  • 129 Views
  • 4 CrossRef citations
  • 0Altmetric
Article
Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia
Zeba Aziz, Javaid Iqbal, Muhammad Aaqib, Muhammad Akram & Asif Saeed
Pages: 1017-1023
Published online: 03 May 2011
AbstractforAssessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia | Full Text | References | PDF (650.7 KB) | Supplemental
  • 445 Views
  • 24 CrossRef citations
  • 0Altmetric
Article
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
Sang Kyun Sohn, Suk Joong Oh, Byung Soo Kim, Hun Mo Ryoo, Joo Seop Chung, Young Don Joo, Soo Mee Bang, Chul Won Jung, Dong Hwan Kim, Sung Soo Yoon, Ho Kim In, Hong Ghi Lee, Jong Ho Won, Yoo Hong Min, June Won Cheong, Joon Seong Park, Ki Seong Eom, Myung Soo Hyun, Min Kyoung Kim, Hawk Kim, Moo Rim Park, Jinny Park, Chul Soo Kim, Hyeoung Joon Kim, Yeo Kyeoung Kim, Eun Kyung Park, Dae Young Zang, Deog Yeon Jo, Joon Ho Moon & Seon Yang Park
Pages: 1024-1029
Published online: 04 Apr 2011
AbstractforTrough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia | Full Text | References | PDF (228.1 KB) | Supplemental
  • 409 Views
  • 27 CrossRef citations
  • 0Altmetric
Article
Effects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population
Shu-Guang Liu, Zhi-Gang Li, Lei Cui, Chao Gao, Wei-Jing Li & Xiao-Xi Zhao
Pages: 1030-1040
Published online: 03 May 2011
AbstractforEffects of methylenetetrahydrofolate reductase gene polymorphisms on toxicities during consolidation therapy in pediatric acute lymphoblastic leukemia in a Chinese population | Full Text | References | PDF (186.9 KB) | Supplemental
  • 272 Views
  • 35 CrossRef citations
  • 0Altmetric
Article
Long-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience
Huiqiang Huang, Zexiao Lin, Xubin Lin, Qingqing Cai, Zhongjun Xia & Wenqi Jiang
Pages: 1041-1048
Published online: 23 May 2011
AbstractforLong-term outcomes of patients with newly diagnosed extranodal natural killer/T-cell lymphoma treated by etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin regimen: a single-institution experience | Full Text | References | PDF (685.6 KB) | Supplemental
  • 348 Views
  • 35 CrossRef citations
  • 0Altmetric
Article
Neurological presentation of Hodgkin lymphoma in the Italian Association of Pediatric Hematology and Oncology LH-2004 protocol
Roberta Burnelli, Elena Fabbri, Giulia Guerrini, Domenico Sperlì & Alfonso D'ambrosio
Pages: 1049-1054
Published online: 03 May 2011
AbstractforNeurological presentation of Hodgkin lymphoma in the Italian Association of Pediatric Hematology and Oncology LH-2004 protocol | Full Text | References | PDF (246.1 KB) | Supplemental
  • 141 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Dose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia
Regina Pileckyte, Mindaugas Jurgutis, Vilma Valceckiene, Mindaugas Stoskus, Egle Gineikiene, Jurgita Sejoniene, Andrius Degulys, Tadas Zvirblis & Laimonas Griskevicius
Pages: 1055-1065
Published online: 23 May 2011
AbstractforDose-dense high-dose methylprednisolone and rituximab in the treatment of relapsed or refractory high-risk chronic lymphocytic leukemia | Full Text | References | PDF (374.6 KB)
  • 790 Views
  • 20 CrossRef citations
  • 0Altmetric

Original Articles: Research

Article
Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma
Hyun Joo Jung, Zheng Chen & Nami McCarty
Pages: 1066-1079
Published online: 23 May 2011
AbstractforStem-like tumor cells confer drug resistant properties to mantle cell lymphoma | Full Text | References | PDF (1.7 MB) | Supplemental
  • 400 Views
  • 19 CrossRef citations
  • 0Altmetric
Article
High rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia
Zsófia Balogh, Lilla Reiniger, Hajnalka Rajnai, Judit Csomor, Ágota Szepesi, Anikó Balogh, Linda Deák, Éva Gagyi, Csaba Bödör & András Matolcsy
Pages: 1080-1084
Published online: 21 Mar 2011
AbstractforHigh rate of neoplastic cells with genetic abnormalities in proliferation centers of chronic lymphocytic leukemia | Full Text | References | PDF (593.1 KB) | Supplemental
  • 163 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
The natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma
Ellen J. Gunn, John T. Williams, Daniel T. Huynh, Michael J. Iannotti, Changho Han, Francis J. Barrios, Stephen Kendall, Carlotta A. Glackin, David A. Colby & Julia Kirshner
Pages: 1085-1097
Published online: 21 Mar 2011
AbstractforThe natural products parthenolide and andrographolide exhibit anti-cancer stem cell activity in multiple myeloma | Full Text | References | PDF (1.2 MB) | Supplemental
  • 672 Views
  • 63 CrossRef citations
  • 0Altmetric
Article
Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases
Sara Raponi, Maria Stefania De Propris, Stefania Intoppa, Maria Laura Milani, Antonella Vitale, Loredana Elia, Omar Perbellini, Giovanni Pizzolo, Robin Foá & Anna Guarini
Pages: 1098-1107
Published online: 24 Feb 2011
AbstractforFlow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases | Full Text | References | PDF (416.4 KB) | Supplemental
  • 2159 Views
  • 172 CrossRef citations
  • 0Altmetric
Article
Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells
Hiroo Hasegawa, Minori Komoda, Yasuaki Yamada, Suguru Yonezawa, Hideaki Tsutsumida, Kazuhiro Nagai, Sunao Atogami, Kazuto Tsuruda, Akemi Osaka, Daisuke Sasaki, Katsunori Yanagihara, Yoshitaka Imaizumi, Kunihiro Tsukasaki, Yasushi Miyazaki & Shimeru Kamihira
Pages: 1108-1117
Published online: 23 May 2011
AbstractforAberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells | Full Text | References | PDF (827.5 KB)
  • 196 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Impact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia
Renata Canalle, Vanessa S. Silveira, Carlos Alberto Scrideli, Rosane G. P. Queiroz, Luiz Fernando Lopes & Luiz Gonzaga Tone
Pages: 1118-1126
Published online: 04 Apr 2011
AbstractforImpact of thymidylate synthase promoter and DNA repair gene polymorphisms on susceptibility to childhood acute lymphoblastic leukemia | Full Text | References | PDF (281.8 KB) | Supplemental
  • 183 Views
  • 23 CrossRef citations
  • 0Altmetric

Teaching case of the month

The Hammersmith hospital hematopathology case of the month: hemophagocytic lymphohistiocytosis secondary to Epstein–Barr virus associated T-cell lymphoma
Rajesh Krishna, Elizabeth Byrne, Janine Burbridge, Nina Salooja & Kikkeri N. Naresh
Pages: 1127-1132
Published online: 21 Mar 2011
AbstractforThe Hammersmith hospital hematopathology case of the month: hemophagocytic lymphohistiocytosis secondary to Epstein–Barr virus associated T-cell lymphoma | Full Text | References | PDF (705.5 KB) | Supplemental
  • 171 Views
  • 3 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Incidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups
Ruth Pettengell & Matthias Schwenkglenks
Pages: 1133-1136
Published online: 11 Feb 2011
First Page PreviewforIncidence of neutropenia, chemotherapy delivery, and use of colony-stimulating factor in patients with non-Hodgkin lymphoma of different age groups | Full Text | References | PDF (371.9 KB) | Supplemental
  • 667 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Letter
Clostridium subterminale sepsis in adult acute lymphoblastic leukemia
Diogo C. Haussen, Francisco Yuri B. Macedo, Caroline V. Caperton & David C. Zuckerman
Pages: 1137-1138
Published online: 23 May 2011
CitationforClostridium subterminale sepsis in adult acute lymphoblastic leukemia | Full Text | References | PDF (132.3 KB)
  • 162 Views
  • 7 CrossRef citations
  • 0Altmetric
Letter
Capillary leak syndrome: initial presentation in a patient with ALK+ anaplastic large cell lymphoma associated with increased levels of serum cytokines
Takako Umemoto, Tsutomu Watanabe, Takeshi Ogose, Rieko Kondo, Tadanori Nakatsu, Akiyoshi Sakata, Michiko Yamashita & Tetsuya Gotho
Pages: 1139-1142
Published online: 04 Apr 2011
First Page PreviewforCapillary leak syndrome: initial presentation in a patient with ALK+ anaplastic large cell lymphoma associated with increased levels of serum cytokines | Full Text | References | PDF (450.6 KB) | Supplemental
  • 173 Views
  • 9 CrossRef citations
  • 0Altmetric
Letter
Familial occurrence of myelodysplastic syndrome with del(5q)
Paola Volpicelli, Roberto Latagliata, Ida Carmosino, Massimo Breccia, Federico Vozella, Marco Mancini, Laura Cannella & Giuliana Alimena
Pages: 1143-1145
Published online: 23 May 2011
First Page PreviewforFamilial occurrence of myelodysplastic syndrome with del(5q) | Full Text | References | PDF (340.6 KB) | Supplemental
  • 89 Views
  • 0 CrossRef citations
  • 0Altmetric
Letter
LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma
Eva Baecklund, Carin Backlin, Mahmoud Mansouri, Lars Klareskog, Johan Askling, Anastasia Nyman Iliadou, Gunilla Enblad, Izidore S. Lossos, Yasodha Natkunam & Richard Rosenquist
Pages: 1146-1149
Published online: 28 Feb 2011
First Page PreviewforLMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma | Full Text | References | PDF (314.6 KB)
  • 166 Views
  • 2 CrossRef citations
  • 0Altmetric
Letter
Light-chain-restricted monocytoid B-cell cluster in reactive lymphadenitis associated with Sjögren syndrome
Masaru Kojima, Naoya Nakamura, Yoshimasa Nakazato, Tadahiko Igarashi, Nobuhide Masawa & Hiroshi Inagaki
Pages: 1150-1152
Published online: 21 Mar 2011
First Page PreviewforLight-chain-restricted monocytoid B-cell cluster in reactive lymphadenitis associated with Sjögren syndrome | Full Text | References | PDF (726.5 KB) | Supplemental
  • 79 Views
  • 0 CrossRef citations
  • 0Altmetric

Letters To The Editor

Letter
Response of hairy cell leukemia to bendamustine
Robert J. Kreitman, Evgeny Arons, Maryalice Stetler-stevenson & Kenneth B. Miller
Pages: 1153-1156
Published online: 04 Apr 2011
First Page PreviewforResponse of hairy cell leukemia to bendamustine | Full Text | References | PDF (419.8 KB) | Supplemental
  • 228 Views
  • 10 CrossRef citations
  • 0Altmetric

Letters to the Editor

Letter
Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias
Helene F. S. Negaard, Per M. Sandset, Svein O. Kolset, Katja Svennevig, Bjørn Østenstad & Per O. Iversen
Pages: 1157-1159
Published online: 04 Apr 2011
First Page PreviewforAssociations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias | Full Text | References | PDF (238.2 KB) | Supplemental
  • 117 Views
  • 0 CrossRef citations
  • 0Altmetric

Corrigendum

Correction
Corrigendum
Page: 1160
Published online: 23 May 2011
CitationforCorrigendum | Full Text | PDF (200.9 KB)
  • 231 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles